Innovation Pharmaceuticals announced that Dr. William F. DeGrado has joined the Company as a Scientific Advisor. In this role, he will help guide the continuing clinical development of Brilacidin, the Company’s defensin-mimetic drug candidate, including against SARS-CoV-2 (COVID-19). Dr. DeGrado, one of the scientific co-discoverers of Brilacidin while a professor at the University of Pennsylvania, is a renowned medicinal chemist and current faculty member at UCSF in the Department of Pharmaceutical Chemistry.